Farmacy

Jun 4 2018

Pharma News, PharmaTutor, pharma marketing news.#Pharma #marketing #news

Pharma News Posted on: 13 November 2017 By: admin In last month, there was lot of hike about osemertinib is being sold illegally in the Hyderabad by private and government hospitals despite a ban by the Drug Controller General of India (DCGI). But on last Friday, DCGI confirmed that only AstraZeneca Pharma India Limited, Bangalore has given permission for import and marketing of cancer drug. Read more about Astrazeneca s osemertinib is only approved in India Log in or register to post comments USFDA Expands Approval of Sprycel® (dasatinib) for children with Philadelphia chromosome Posted on: 11 November 2017 By: …

Jun 4 2018

Study: One-third of docs trust pharma content on HCP sites – Medical Marketing and Media,

Study: One-third of docs trust pharma content on HCP sites Drugmakers should invest more on HCP-facing websites where physicians spend more of their time, the study found. Only 34% of physicians find pharmaceutical content on HCP sites to be trustworthy, according to a new study by Decision Resources Group’s Manhattan Research. “We found that pharma is missing the mark when it comes to providing online content that physicians need in an easy-to-use way,” said Kelly Pinola, senior analyst of physician research at DRG. In February and March this year, the healthcare analytics company surveyed 2,784 U.S. physicians in more than …

Jun 4 2018

New Jersey suing Purdue Pharma for fueling state’s opioid crisis – NY Daily News, pharma

New Jersey suing Purdue Pharma for fueling state’s opioid crisis with deceptive marketing strategy New Jersey is one of 11 states that are suing Perdu over deceptive marketing strategy that is feeding the nation’s opioid crisis. New Jersey on Tuesday sued Purdue Pharma LP, accusing the maker of the chronic pain medication OxyContin of fueling the state’s opioid crisis through deceptive marketing to doctors and patients, including the elderly and the “opioid-naive.” The state’s attorney general, Christopher Porrino, faulted what he called Purdue’s “almost inconceivable callousness and irresponsibility” in a decade-long campaign of downplaying the risks and exaggerating the benefits …

May 29 2018

Biotech Industry, Biotech News, Biotechnology Articles, pharma marketing news.#Pharma #marketing #news

pharma marketing news Certain microRNAs in the saliva of concussion patients could help gauge the severity of concussions and predict the length of concussion symptoms. Toxicity knocks Ardelyx s hyperkalemia hopes back to preclinic Unexpected side effects have spelled the end for Ardelyx’s drug candidate to treat elevated potassium levels in the blood, which was in phase 3 testing. Cytokinetics cans lead drug after phase 3 ALS wipeout Cytokinetics canned tirasemtiv after it failed to beat placebo against the primary endpoint or any of the secondary goals in an ALS trial. Step Pharma bags cash for CTPS1 autoimmune R D …

May 17 2018

Pharma rep visits? They – re redundant, doctors say in new survey, FiercePharma, pharma digital

Pharma rep visits? They re redundant, doctors say in new survey Tell physicians something they don’t know. That’s one of the key messages that came from the ePharma Physicians annual study, in which doctors claimed 51% of the time, sales reps are showing them redundant information during visits. The sales rep and physician study, now in its 15th year from DRG Digital’s Manhattan Research, found doctors say reps spend most of their time on material they already have or found on their own. And the “stale detail” is even worse in some specialty areas. Some 68% of the time pharma …

May 17 2018

Pharmaceutical industry news, articles, jobs, reports, advice and services, pharma digital marketing.#Pharma #digital #marketing

First Herceptin biosimilar cleared in Europe Ontruzant is approved for all the same indications as Roche s blockbuster EMA forges closer ties with HTA umbrella group Agrees joint work plan with the European Network for Health Technology Assessment Novartis’ orphan drug Tasigna wins EU expanded indication The CML medication can now treat paediatric patients Amsterdam picked to host the European Medicines Agency But regulator faces a challenging relocation project to depart from London Concordia accused of overcharging NHS for thyroid drug The pharma firm said to have abused its position within the UK market Sales news Research news The state …

May 10 2018

Early Phase – Late Phase Clinical Research, Advanced Pharma, pharma marketing research.#Pharma #marketing #research

Early Phase We ensure that all Early Phase initiatives achieve both strategic and scientific objectives, first in man to market Welcome! Late Phase We Provide comprehensive Late Phase testing services and ensure the highest level of quality and integrity with our dedicated team of experts Welcome! Volunteers Together with your participation in Clinical Trials, we can advance medicine, develop new treatments and make all lives better. Who is Advanced Pharma – Miami? Advanced Pharma – Miami is a dedicated Phase I­-IV Clinical Research Facility. With our 40,000 sq. ft. turnkey facility we house a 100+ bed capacity Phase I unit …

May 6 2018

Kite Pharma – s ASCO ads aim to prep docs on CAR-T ahead of FDA

Kite Pharma s ASCO ads aim to prep docs on CAR-T ahead of FDA approval If you’re looking for ASCO, just follow the ads. They’re scattered like bread crumbs. But among all those many promos for oncology therapies, only one campaign highlighted a class of drugs that hasn’t received FDA approval yet. That would be Kite Pharma’s CAR-T therapy posters, seen at O’Hare International Airport and around the conference. The way Kite sees it, the closely watched drug class, expected to hit the market later this year, needs explaining, and the company used ASCO as a chance to point docs …

Apr 19 2018

European Medicines Agency – Partners & Networks – Pharmaceutical industry, pharmaceutical marketing agency.#Pharmaceutical #marketing #agency

Pharmaceutical industry The pharmaceutical industry is one of the European Medicines Agency’s (EMA) main stakeholders. Interacting with pharmaceutical companies has been a major part of EMA’s daily business since it began operating. These interactions are guided by a formal framework that rests on the principles of accountability, transparency and broad representation. EMA routinely interacts with pharmaceutical companies through various channels, including: overseeing the centralised authorisation procedure, whereby pharmaceutical companies apply for a single marketing authorisation valid throughout the European Union (EU); providing scientific advice to companies to support research and development activities; offering targeted information to micro, small and medium-sized …

Apr 18 2018

Digitas Health – The Agency of Now, pharmaceutical marketing agency.#Pharmaceutical #marketing #agency

Digitas Health is a creative agency purpose-built to connect health and wellness brands with peoples’ desire to make healthy, confident choices for themselves and for their loved ones. We call this “Helping not Selling.” Years ago, in a time before “micro-influencers” traveled with photographers and mobile lighting kits to capture and document meticulously staged snaps, I worked on a social media campaign that taught me an important lesson – [ ] Digitas Health, the Publicis-owned connected health agency that created the eye-catching eyelove® campaign for Shire plc (LSE: SHP, NASDAQ: SHPG) last year, is helping the leading global biotechnology company’s …